Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 857 M998 M969 M1.11 B1.05 B1.18 B 4.31 B Research & development 568 M610 M587 M589 M638 M672 M 2.49 B Operating income 38 M612 M1.63 B269 M86 M758 M 2.74 B Non-Operating Income, Total 135 M167 M167 M124 M195 M176 M 662 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 173 M190 M180 M168 M155 M183 M 686 M Unusual income/expense -38 M-23 M-13 M-44 M40 M-7 M -24 M Pretax income 173 M779 M1.79 B393 M281 M897 M 3.36 B Equity in earnings —————— — Taxes 19 M137 M418 M52 M121 M81 M 672 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 154 M642 M1.37 B341 M160 M816 M 2.69 B Discontinued operations —————— — Net income 154 M642 M1.37 B341 M160 M816 M 2.69 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 155 M643 M1.38 B341 M160 M816 M 2.69 B Basic earnings per share (Basic EPS) 0.251.042.250.560.271.38 4.46 Diluted earnings per share (Diluted EPS) 0.241.032.210.550.261.37 4.39 Average basic shares outstanding 621 M615 M611 M613 M598 M592 M — Diluted shares outstanding 632 M626 M621 M623 M608 M597 M — EBITDA 63 M————— — EBIT 38 M612 M1.63 B269 M86 M758 M 2.74 B Cost of revenue 506 M544 M549 M487 M581 M633 M 2.25 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 25 M————— —